Latest oncology News

Ashurst advises Atomic Oncology on series seed capital raise
ARPANSA leads world first in film dosimetry
Digital health support systems help improve health for people with breast cancer
Breast cancer support comes to Ballarat as BCNA welcomes back face-to-face information forums
First quarter 2022 results
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
Imugene says first cohort two patient dose in phase 1 clinical trial
Race receives human ethics approval for new trial
Seniors Festival Awards announced
AstraZeneca aims to transform oncology treatment landscape with diverse early pipeline and novel combinations
Update on CALLA Phase III trial of concurrent use of Imfinzi and chemoradiotherapy
US FDA grants new orphan designation to Noxopharm’s Veyonda
Western Australia Covid update as at 2 March
Arovella Therapeutics closes over-subscribed share purchase plan
AGA recommends shared decision-making approach for treatment of hepatocellular carcinoma
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial
New Epworth Eastern oncology ward opens
Lynparza plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic
Baylor faculty elected to American Society for Clinical Investigation
Service of doctors recognised once again in Honours List
Young cancer rates rising in SA
First patient dosed in phase I/IIa trial of lung cancer immunotherapy vaccine
Providing another option for newly diagnosed women with this deadly disease
Enhertu granted Priority Review in US for patients with HER2-positive metastatic breast cancer treated with prior anti-HER2-based
$2M grant will fund Penn State research studies on preventing muscle wasting
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Cuts to Telehealth puts people with breast cancer at risk as Covid cases surge
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Disparities in breast cancer care quality have reduced
New Mildura cancer treatment centre will offer local care to local patients
Enhertu additional analyses further reinforce ground-breaking efficacy
Targeting Stem Cell Signaling Could Halt Liver Cancer Progression Elucidating novel therapeutic target
‘Miracle dog’ goes into fifth remission from lymphoma
Oral drug enhances radiation therapy for cancer
Ludwig Cancer Research study identifies cellular interactions essential to immune attack on ovarian tumors
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
Delivering Better Cancer Treatment Closer to Home
New discovery tackles treatment-resistant melanoma
Scientists uncover key vulnerability of aggressive lymphomas
Siblings of Childhood Cancer Falling Between Cracks: Call for Action
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-positive metastatic breast cancer treated with one
SUDA Pharmaceuticals announces ‘firm commitments’ on capital raise
Children’s Hospital welcomes first patients to new ward
Ramsay Health Care to build $133m private hospital in Melbourne’s north
TGA grants priority review for Telix Pharmaceuticals’ TLX591-CDx
NT health Ce resigns
China Grand Pharma signs A$400m commercial partnership with Telix Pharma